PARG inhibition augments CHK1 inhibitor-induced replication stress and synergistically kills ovarian cancer cells

被引：1
|
作者：
Acharya, Ganesh
Mani, Chinnadurai
Reedy, Mark B.
Palle, Komaraiah
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2667
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2667
引用
收藏
页数：2
相关论文
共 50 条
  • [1] CHK1 inhibitor induced PARylation by targeting PARG causes excessive replication and metabolic stress and overcomes chemoresistance in ovarian cancer
    Acharya, Ganesh
    Mani, Chinnadurai
    Sah, Naresh
    Saamarthy, Karunakar
    Young, Robert
    Reedy, Mark B.
    Sobol, Robert W.
    Palle, Komaraiah
    CELL DEATH DISCOVERY, 2024, 10 (01)
  • [2] Targeting the PI3K/mTOR Pathway Augments CHK1 Inhibitor-Induced Replication Stress and Antitumor Activity in High-Grade Serous Ovarian Cancer
    Huang, Tzu-Ting
    Brill, Ethan
    Nair, Jayakumar R.
    Zhang, Xiaohu
    Wilson, Kelli M.
    Chen, Lu
    Thomas, Craig J.
    Lee, Jung-Min
    CANCER RESEARCH, 2020, 80 (23) : 5380 - 5392
  • [3] The combination of Chk-1 and ATR inhibitor synergistically kills cancer cells
    Sanjiv, K.
    Hagenkort, A.
    Reaper, P. M.
    Koolmeister, T.
    Mortusewicz, O.
    Schultz, N.
    Scobie, M.
    Berglund, U. W.
    Charlton, P. A.
    Pollard, J. R.
    Helleday, T.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 81 - 81
  • [4] CHK1 inhibition exacerbates replication stress induced by IGF blockade
    Wu, Xiaoning
    Seraia, Elena
    Hatch, Stephanie B.
    Wan, Xiao
    Ebner, Daniel V.
    Aroldi, Francesca
    Jiang, Yanyan
    Ryan, Anderson J.
    Bogenrieder, Thomas
    Weyer-Czernilofsky, Ulrike
    Rieunier, Guillaume
    Macaulay, Valentine M.
    ONCOGENE, 2022, 41 (04) : 476 - 488
  • [5] CHK1 inhibition exacerbates replication stress induced by IGF blockade
    Xiaoning Wu
    Elena Seraia
    Stephanie B. Hatch
    Xiao Wan
    Daniel V. Ebner
    Francesca Aroldi
    Yanyan Jiang
    Anderson J. Ryan
    Thomas Bogenrieder
    Ulrike Weyer-Czernilofsky
    Guillaume Rieunier
    Valentine M. Macaulay
    Oncogene, 2022, 41 : 476 - 488
  • [6] Chk1 inhibitor-induced DNA damage increases BFL1 and decreases BIM but does not protect human cancer cell lines from Chk1 inhibitor-induced apoptosis
    Massey, Andrew J.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (05): : 2293 - +
  • [7] Inhibition of ATR-dependent feedback activation of Chk1 sensitises cancer cells to Chk1 inhibitor monotherapy
    Massey, Andrew J.
    CANCER LETTERS, 2016, 383 (01) : 41 - 52
  • [8] Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress
    Zhang, Yao
    Lai, Jinzhi
    Du, Zhanwen
    Gao, Jinnan
    Yang, Shuming
    Gorityala, Shashank
    Xiong, Xiahui
    Deng, Ou
    Ma, Zhefu
    Yan, Chunhong
    Susana, Gonzalo
    Xu, Yan
    Zhang, Junran
    ONCOTARGET, 2016, 7 (23) : 34688 - 34702
  • [9] Loss of FGFR2 sensitizes neuroblastoma cells to CHK1 inhibitor-induced apoptosis
    Ando, Kiyohiro
    Ohira, Miki
    Suenaga, Yusuke
    Kamijo, Takehiko
    Nagase, Hiroki
    Kobayashi, Shinichi
    Wada, Satoshi
    CANCER SCIENCE, 2021, 112 : 537 - 537
  • [10] Replication stress is a determinant of synergy between gemcitabine and Chk1 inhibition
    Koh, S. B.
    Courtin, A.
    Boyce, R.
    Boyle, B.
    Richards, F. M.
    Jodrell, D. I.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 16 - 16
12345